a website banner telling users to subscribe to it's newsletter

Breaking News

Australia's Second-Generation Bionic Eye Shows Promise in RP Clinical Trial
Australia's Second-Generation Bionic Eye Shows Promise in RP Clinical Trial Jun 11, 2024 Australia's second-generation bionic eye has demonstrated "substantial improvement" in functional vision, daily activities, and quality of life for four participants over a period of more than two and a half years.
Eye-light® Device Receives CE Mark for Dry AMD and Extended Anterior Segment Pathologies
Eye-light® Device Receives CE Mark for Dry AMD and Extended Anterior Segment Pathologies Jun 07, 2024 Espansione Group announced that it has received CE (MDR) approval for its flagship device, eye-light®, covering a broad spectrum of conditions, including both new retinal and corneal pathologies.
Reuters: Italy Launches Probe into Pharma Giants for Market Manipulation
Reuters: Italy Launches Probe into Pharma Giants for Market Manipulation Jun 06, 2024 Italy's antitrust regulator has initiated a probe into several pharmaceutical giants, including Novartis, amid suspicions of anti-competitive practices in the sale of a drug targeting eye conditions.

 

Industry News

Beacon Therapeutics Initiates VISTA Trial with AGTC-501 for X-Linked RP
Beacon Therapeutics Initiates VISTA Trial with AGTC-501 for X-Linked RP Jun 13, 2024 Beacon Therapeutics announced the treatment of the first patient in its pivotal VISTA clinical trial with its lead asset, AGTC-501 (laruparetigene zovaparvovec) for X-linked retinitis pigmentosa.
Oculis' Licaminlimab Demonstrates Promising Results in Phase 2B RELIEF Trial for DED
Oculis' Licaminlimab Demonstrates Promising Results in Phase 2B RELIEF Trial for DED Jun 12, 2024 Oculis Holding announced positive topline results from its phase 2b RELIEF trial, shedding light on the efficacy of licaminlimab, an innovative anti-TNFα biologic eye drop, in addressing dry eye disease (DED).
Skye Bioscience Shifts Focus After Phase 2 Glaucoma Trial Fails
Skye Bioscience Shifts Focus After Phase 2 Glaucoma Trial Fails Jun 11, 2024 Skye Bioscience's phase 2a clinical trial of its SBI-100 ophthalmic emulsion in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT) has failed to meet its primary endpoint for lowering intraocular pressure (IOP).

Ophthalmic Research News

Novel Device Targets Dry Eye and Beyond with Thermal Imaging
Novel Device Targets Dry Eye and Beyond with Thermal Imaging Jun 13, 2024 A groundbreaking innovation in ocular health assessment is on the horizon, as a new University of Waterloo spinoff company, ThermOcular AI, unveils its pioneering approach to eye temperature monitoring.
Teprotumumab Shows Long-Lasting Benefits for Thyroid Eye Disease Patients
Teprotumumab Shows Long-Lasting Benefits for Thyroid Eye Disease Patients Jun 13, 2024 Research indicates that most patients with thyroid eye disease (TED) treated with teprotumumab did not require additional treatments nearly two years later.
Robot Radiotherapy Could Improve Treatment for Wet AMD
Robot Radiotherapy Could Improve Treatment for Wet AMD Jun 12, 2024 Researchers from King's College London, in collaboration with doctors at King's College Hospital NHS Foundation Trust, have achieved a breakthrough in treating a debilitating eye disease using a new robot system.

Ophthalmic Blog

Your Complete Guide to Cataract Surgery in 2024
Your Complete Guide to Cataract Surgery in 2024 Jun 10, 2024 Cataract surgery is a safe, effective procedure that improves vision by removing cloudy lenses from the eyes and replacing them with artificial lenses.
The Revolutionary Phacoemulsification Procedure: An In-Depth Look at Modern Cataract Surgery
The Revolutionary Phacoemulsification Procedure: An In-Depth Look at Modern Cataract Surgery Jun 10, 2024 The phacoemulsification procedure has transformed cataract surgery, offering a less invasive and more efficient method for cataract removal.
Intracapsular Cataract Extraction (ICCE): Indications, Complications, and Management
Intracapsular Cataract Extraction (ICCE): Indications, Complications, and Management Jun 10, 2024 Intracapsular Cataract Extraction (ICCE) is a surgical technique where the entire lens and the surrounding capsule are removed from the eye.
Ophthalmology Breaking News Subscribe